Evaluation of a Switchable Acrylic Adhesive Drape for Safer Removal in Negative Pressure Wound Therapy Applications.
Launched by GLOBAL BIOMEDICAL TECHNOLOGIES, LLC · Dec 3, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new type of medical adhesive drape designed for negative pressure wound therapy (NPWT), which is a treatment used for healing various types of wounds, especially those that are difficult to heal. The main goal is to see if the new drape, called Comfort Release®, can reduce skin injuries and pain during removal compared to the current standard drape. Researchers will enroll up to 300 participants, including post-surgical patients and those with chronic wounds, who are 18 years or older and can communicate their experiences.
Participants in the trial can expect to use either the Comfort Release® drape or the standard drape during their treatment. They will provide feedback on their pain levels and any skin irritation they experience. The study aims to find out if the new drape makes it easier and less painful to remove while still being effective in keeping wounds sealed. If you or a loved one are considering participation, it's important to know that individuals with specific allergies to adhesives or who have had recent NPWT treatment may not be eligible.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. 18 years or older post-surgical inpatients with a plan of treatment using NPWT
- • 2. Able to communicate and consent to participation in the study
- • 3. Access to V.A.C. by KCI drape and NPWT kits
- • 4. Able to report pain level using a pain scale.
- Exclusion Criteria:
- • 1. History of known hypersensitivity to acrylic adhesives
- • 2. History of known hypersensitivity to isopropyl alcohol
- • 3. NPWT treatment within past 3 months
- • 4. The patient is expected to be unconscious during the drape removal/change
- • 5. Under the age of 18 years 6. Unable to give consent, including language barrier, unless an interpreter is readily available.
About Global Biomedical Technologies, Llc
Global Biomedical Technologies, LLC is an innovative clinical trial sponsor dedicated to advancing healthcare through the development and evaluation of cutting-edge biomedical solutions. Specializing in the design and management of clinical studies, the company leverages state-of-the-art technologies and a robust network of clinical research sites to ensure the efficient and ethical conduct of trials. With a commitment to enhancing patient outcomes and accelerating the delivery of transformative therapies, Global Biomedical Technologies collaborates with industry partners to navigate the complexities of regulatory landscapes and foster breakthroughs in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
New York, New York, United States
Patients applied
Trial Officials
Howard S Rosing, MD, PhD
Principal Investigator
Global Biomedical Technologies, LLC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported